TuesdayNov 14, 2023 1:00 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces Strong Q3 2023 Results Including 550% YoY EBITDA Growth and 5-Year-Record Net Profit

SuperCom Ltd. (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT and cybersecurity sectors, today announced financial and operating results for the three and nine months ended Sept. 30, 2023. “We are excited to announce exceptional operational performance for Q3 2023, which is reflected in our financial results. A 5-year record net profit, remarkable 550% growth in EBITDA and 74% growth in gross profit margins are clear indicators of the successful execution of our growth strategy. The significant increase in the company’s profit margins is driven by the forward momentum we’ve maintained across our projects, where margins…

Continue Reading

FridayNov 03, 2023 12:35 pm

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Announces Plans to Release Q3 2023 Financial Report, Host Corporate Update Call

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, has announced plans to report its financial results for Q3 2023. The company will release the results on Nov. 10, 2023, before the market opens. In addition, the company announced plans to host a conference call and webcast that same day. During the call, key company leaders will discuss the Q3 financial report as well as provide an update on its clinical programs and corporate activities; the call will also include time for a Q&A. To access the call, individuals should dial 1-877-407-0789 (domestic)…

Continue Reading

MondayOct 16, 2023 11:20 am

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Closes on $4M Registered Direct Offering

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, closed on its previously announced registered direct offering. The offering was comprised of 2,424,243 shares of Class A common stock or common stock equivalents priced at $1.65 per share, or common stock equivalent. In addition, Longeveron issued unregistered Series A warrants in a concurrent private placement; the private placement included 2,424,243 shares of LGVN common stock and unregistered Series B warrants. The warrants, which have an exercise price of $1.65 per share, are…

Continue Reading

ThursdayAug 17, 2023 1:11 pm

QualityStocksNewsBreaks — Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) Issues 100K Shares to Fulfill Mineral Property Option Agreement

Reflex Advanced Materials (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2), a mineral exploration company, has issued 100,000 common shares to fulfill its obligations to date outlined in a mineral property option agreement. According to the announcement, the issue of shares is in connection with the Sept. 1, 2021, agreement, which is between the company and Alex Pleson and which gives Reflex Advanced Materials the sole and exclusive right to acquire up to a 100% interest in the Zigzag lithium property. The ZigZag lithium property includes eight mining claims comprising an estimated 2,710 hectares near Crescent Lake, Ontario, a region known for…

Continue Reading

MondayAug 07, 2023 2:35 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to Host 2Q Conference Call and Webcast

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced plans to hold its Second Quarter Town Hall Update to share current events and 2023 financial highlights following the filing of its 10-Q update with the U.S. Securities and Exchange Commission. The company’s CEO and Chairman William Santana Li will deliver a pre-recorded video update at the top of the meeting to cover Q2 2023 performance metrics followed by a live question-and-answer session with supporters, investors and analysts in an intimate online forum with no moderator. The announcement reads, “The conference…

Continue Reading

ThursdayJul 20, 2023 1:10 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Results from ‘Groundbreaking’ Sponsored Study Measuring Psychedelic Effects

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is reporting on the release of study findings. Cybin sponsored the study, which was conducted by Kernel, a leader in noninvasive neuroimaging. Titled “Measuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans using TD-fNIRS,” the study was published in “Scientific Reports from the Nature Portfolio of Journals” and evaluated the ability of Kernel’s Flow1 system to capture and analyze brain changes resulting from the administration of a psychoactive substance. According to the announcement, the single-blind, placebo-controlled…

Continue Reading

ThursdayJul 06, 2023 2:02 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Adds to List of Growing Sales; Receives Two New Orders

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, continues to see added sales and is building on its 2023 revenue. The company has received an order for an ASR and an order for two K1 Call Boxes. According to the announcement, the ASR order came from one of the largest churches in the nation; the church has more than 35,000 people who attend congregations on 17 campuses. The church anticipates having Knightscope’s ASR patrol the parking lot of one its largest campus, a 105-acre site that includes an auditorium which seats…

Continue Reading

WednesdayJun 21, 2023 2:19 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Secures US Patent for SPU-21 Treatment for Autoimmune Disease

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent 16/825,371 titled “Peptide-Targeted Liposomal Delivery for Treatment, Diagnosis and Imaging of Diseases and Disorders.” According to the announcement, the new patent claims cover the company’s portfolio drug SPU-21, a peptide-guided anti-arthritis drug, as a method of selectively targeting inflamed synovial tissue. “Our SPU-21 liposomal homing peptides, licensed from the University of Maryland, Baltimore, are able to identify markers of arthritic inflammation in joints and have potential for the development…

Continue Reading

FridayJun 09, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields Most Convincing Evidence for Anti-Inflammatory Actions of CBD with its DehydraTECH(TM)-CBD

Lexaria just announced additional findings from its HYPER-H21-4 human clinical study, highlighting significant reductions in several pro-inflammatory biomarkers associated with cardiovascular disease This has been termed as “the most convincing evidence in humans,” ultimately showcasing the potential of the company’s patented DehydraTECH(TM)-processed CBD Other third-party research studies have failed to demonstrate a sustained decrease in resting blood pressure with oral CBD dosing. More so, none have yielded evidence of the anti-inflammatory actions of CBD until Lexaria’s HYPER-H21-4 human clinical study Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced additional findings from its HYPER-H21-4 human clinical…

Continue Reading

MondayJun 05, 2023 10:15 am

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Inks Contract with 4th Largest Public University in Texas

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has received a new order for emergency communication devices. Specifically, the order is from Texas State University (“TXST”) for 13 K1 Blue Light E-Phones. “Although it’s common to think of a cell phone as the easiest solution for calling for help in an emergency, there are countless times when mobile communications fail due to a lack of cellular service, a device that gets lost or runs out of battery, or even acceptable use policies on campus,” the announcement states. “Knightscope’s emergency communication systems…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered